The European Technology Platform on Nanomedicine is holding its Annual Event & General Assembly in San Sebastián.
The event is organised by CIC nanoGUNE and nanoBasque and will take place on 15 and 16 October
The Annual Event & General Assembly of the European Technology Platform on Nanomedicine (ETPM) will take place on 15 and 16 October in San Sebastian. The event will be held at the CIC nanoGUNE nanoscience Cooperative Research Centre facilities, and is co-organised by this organisation and the Basque Government’s nanoBasque agency.
Future priorities of nanomedicine research and innovation will be discussed at the ETPN meeting. The guidelines will be based on the Strategic Research and Innovation Agenda (SRIA), which describes the ETPN’s approach to the future development of nanomedicine and lists the research priorities that will be put forward to the European Commission, member states and funding organisations, to be applied in calls for projects.
The event aims to bring together all current or potential nanomedicine stakeholders, and to promote links and networking between the people involved in the sector. There will be several activities such as short presentations, social dinners, poster presentations, workshops on different topics, and visits to different local nanoscience centres, such as CIC biomaGUNE, Tecnalia, IK4-CIDETEC and CIC nanoGUNE.
A club aimed especially at SMEs, SME Square, will be launched for these companies to identify common training needs, and discuss translation, technology transfer and business opportunities. This club will also look for suitable solutions to help SMEs overcome barriers and promote success factors and best practices.
About the ETPN
The European Technology Platform on Nanomedicine is an association that was established in 2005, through which industrial and academic experts work together to promote research and the implementation of joint activities in the area of nanotechnology in medicine. This organisation has published a series of strategic documents describing the needs and work plans for nanomedicine research in Europe.
The ETPN has also helped to set up many projects funded by the European Union, and supports its members in joint ventures and in the improvement of communication between them, and with the European Commission and EU Member States.